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Valvular Heart Disease

Conventional Aortic Valve Replacement for Elderly Patients
in the Current Era
Kentaro Yamane, MD, PhD; Hitoshi Hirose, MD, PhD; Benjamin A. Youdelman, MD;
Linda J. Bogar, MD; James T. Diehl, MD

Background: Because of the rising expectation of prolonged life in the general population and the recent recognition of undertreated aortic valve disease in the elderly, updating the available results of aortic valve surgery is
imperative, especially considering the rapid evolution of the transcatheter valve implantation procedure.
Methods and Results: Between 1997 and 2010, 308 patients aged 70 years or older underwent aortic valve replacement (AVR) for aortic stenosis (AS). Short- and long-term results were analyzed and risk factors for long-term
mortality were determined. Mean age was 78.5 years and 124 patients were aged 80 or older. Concomitant coronary
artery bypass grafting (CABG) was performed in 46% of the cases. Mean left ventricular ejection fraction (LVEF)
was 52%. Overall observed and expected operative mortality using the Society of Thoracic Surgeons-Predicted Risk
of Mortality score was 3.9% and 4.8%, respectively. Overall survival rates at 1, 5, and 10 years were 88.6%, 71.6%,
and 31.8%, respectively. Predictors of long-term mortality included diabetes; preoperative shock; LVEF ≤40%; New
York Heart Association functional class III or IV; and age.
Conclusions: Short- and long-term results of conventional AVR in the elderly prove it to be durable and, especially
in relatively low-risk patients and patients who require concomitant CABG, operative mortality is reasonably low.
Conventional AVR ± CABG remains the gold standard for elderly patients with AS.   (Circ J 2011; 75: 2692 – 2698)
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A

ortic stenosis (AS) is the most frequent valvular lesion
in the elderly.1 The prevalence rates of aortic valve
sclerosis (leaflet thickening, stiffness, and/or calcification without stenosis) in those aged 75–85 years and in those
older than 85 are 35% and 48%, respectively; furthermore, in
these age groups, 2.4% and 4%, respectively, have AS.2 The
elderly population in the United States is projected to grow
and the 80 and older population will reach 18.9 million by 2030
from 11.5 million in 2010.3 With the rapidly increasing geriatric population, it is common in current practice to have aged
patients referred for surgical treatment of AS. In 2006, in the
United States, approximately 40% of patients undergoing
aortic valve replacement (AVR) were 75 years old or older.4
AVR is the gold standard for the treatment of severe AS.
Previous studies have shown acceptable short- and long-term
outcomes, as well as improved quality of life in elderly patients.5–10 Ongoing studies of transcatheter aortic valve
implantation (TAVI) have demonstrated its feasible short- and
mid-term results in patients who were not considered suitable
candidates for conventional AVR.12–14 Because of both the increasing number of elderly patients with multiple comorbidities

and recent awareness of the underdiagnosed or undertreated
patient population with aortic valve disease, it is imperative to
analyze the operative outcome of conventional AVR in current
practice within the context of rapidly evolving transcatheter
valve implantation procedures. The aim of this study was to
evaluate operative mortality and morbidity in elderly patients
aged 70 or older who underwent conventional AVR and to
investigate the long-term outcomes of these patients.

Methods
Patient Population
From December 1997 to September 2010, a total of 308 patients aged 70 or older underwent AVR for AS at Thomas
Jefferson University Hospital. We excluded those patients
with dominant aortic regurgitation, aortic valve endocarditis,
and concomitant non-cardiac or cardiac procedures other than
coronary artery bypass grafting (CABG). Information was
collected retrospectively by reviewing the medical chart and
included: preoperative patient demographics; preoperative
hemodynamic parameters and echocardiographic data; pre-
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Table 1. Preoperative Patient Demographics
All patients
(n=308)

Age 70–79 years
(n=184)

Age 80–92 years
(n=124)

P value

78.5±5.0

75.1±2.8

83.5±2.7

<0.001

   Male

169 (55)

104 (57)

65 (52)

0.478

   Female

139 (45)

80 (44)

59 (48)

Caucasian, n (%)

Age
Sex, n (%)

287 (93)

169 (92)

118 (95)

0.258

History of smoking, n (%)

70 (23)

45 (25)

25 (20)

0.378

Chronic lung disease, n (%)

67 (22)

43 (23)

24 (19)

0.042

Diabetes mellitus, n (%)

81 (26)

55 (30)

26 (21)

0.081

Renal dysfunction (S-Cr >
– 2.0 mg/dl), n (%)

18 (5.8)

11 (6.0)

7 (5.6)

0.903

7 (2.3)

4 (2.2)

3 (2.4)

0.999

Peripheral vascular disease, n (%)

29 (9.4)

15 (8.2)

14 (11)

0.355

Carotid disease, n (%)

21 (6.8)

8 (4.3)

13 (11)

0.036

Previous stroke, n (%)

29 (9.4)

11 (6.0)

18 (15)

0.012

234 (77)

147 (80)

87 (70)

0.050

40 (13)

24 (13)

16 (13)

0.971

Body mass index (kg/m2)

28.3±5.8

29.0±6.2

27.2±5.0

0.007

Body surface area (m2)

1.87±0.23

1.90±0.23

1.81±0.22

0.001

Chronic hemodialysis, n (%)

Hypertension, n (%)
Previous cardiac surgery, n (%)

Data are presented as mean ± standard deviation or number (percentage).
S-Cr, serum creatinine.

Table 2. Preoperative Hemodynamics and Cardiac Profiles
All patients
(n=308)

Age 70–79 years
(n=184)

Age 80–92 years
(n=124)

P value

52.2±14.2

53.0±13.6

50.9±15.2

0.209

73 (24)

38 (21)

35 (29)

0.125

202 (66)

115 (63)

87 (70)

0.165

Previous myocardial infarction, n (%)

57 (19)

26 (14)

31 (25)

0.016

Unstable angina, n (%)

39 (13)

19 (10)

20 (16)

0.133

   I

38 (12)

33 (18)

5 (4.0)

<0.001

   II

91 (30)

64 (35)

27 (22)

   III

137 (45)

70 (38)

67 (54)

   IV

42 (14)

17 (9)

25 (20)

Cardiogenic shock, n (%)

11 (3.6)

5 (2.7)

6 (4.8)

0.360

Congestive heart failure, n (%)

61 (20)

29 (16)

32 (26)

0.032
<0.001

LVEF (%)
LVEF <
– 40%, n (%)
Coronary artery disease, n (%)

NYHA functional class, n (%)

Aortic valve lesion, n (%)
   AS

267 (87)

149 (81)

118 (95)

   AS + AI (moderate or more)

41 (13)

35 (19)

6 (4.8)

Peak pressure gradient (mmHg)

68±23

67±22

68±245

0.714

Mean pressure gradient (mmHg)

44±15

44±15

45±16

0.372

0.74±0.20

0.76±0.20

0.71±0.20

0.070

STS-PROM (%)

4.8±5.4

3.8±3.1

6.3±7.3

0.001

   <7.5%, n (%)
   >
– 7.5–<15%, n (%)

274 (89)

169 (92)

105 (85)

0.105

27 (8.8)

11 (6.0)

16 (13)

7 (2.3)

4 (2.2)

3 (2.4)

Aortic valve area (cm2)

   >
– 15%, n (%)

Data are presented as mean ± standard deviation or number (percentage).
LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; AS, aortic stenosis; AI, aortic insufficiency;
STS-PROM, Society of Thoracic Surgeons Predicted Risk of Mortality.

operative comorbidities; details of operative procedure; and
postoperative comorbidities. The Society of Thoracic Surgeons
Predicted Risk of Mortality (STS-PROM) score was calculated in all patients, including isolated AVR (n=166) and AVR
with concomitant CABG (n=142), using the online calculator, available at the STS website (http://209.220.160.181/

STSWebRiskCalc261/). Operative mortality was defined as
death during hospitalization or within 30 days after surgery.
Patients’ survival status was followed and confirmed by Social
Security Death Index search until October 2010. This study was
reviewed and approved by the Thomas Jefferson University
institutional review board.
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Table 3. Operative Data
All patients
(n=308)

Age 70–79 years
(n=184)

Age 80–92 years
(n=124)

   Elective

217 (70.5)

136 (73.9)

81 (65.3)

   Urgent

82 (26.6)

44 (23.9)

38 (30.6)

9 (2.9)

4 (2.2)

5 (4.0)

297 (96.4)

178 (96.7)

119 (96.0)

11 (3.6)

6 (3.3)

5 (4.0)

6 (1.9)

2 (1.1)

4 (3.2)

   19

92 (29.9)

50 (27.2)

42 (33.9)

   21

124 (40.3)

79 (42.9)

45 (36.3)

   23

71 (23.1)

47 (25.5)

24 (19.4)

   25

12 (3.9)

4 (2.2)

8 (6.5)

3 (1.0)

2 (1.1)

1 (0.8)

142 (46.1)

86 (46.7)

56 (45.2)

0.785

91±28

94±29

88±26

0.069

119±36

120±36

117±36

0.538

Age 80–92 years
(n=124)

P value

Timing of surgery, n (%)

P value
0.233

   Emergency
Prosthesis type, n (%)

0.761

   Bioprosthesis
   Mechanical
Prosthesis size (mm), n (%)

0.167

   17

   27–29
Concomitant CABG, n (%)
Cross-clamp time
Bypass time

Data are presented as mean ± standard deviation or number (percentage).
CABG, coronary artery bypass grafting.

Table 4. Postoperative Complications and Course
All patients
(n=307)

Age 70–79 years
(n=183)

Perioperative IABP use, n (%)

20 (6.5)

12 (6.5)

8 (6.5)

0.980

Reexploration for bleeding, n (%)

16 (5.2)

11 (6.0)

5 (4.0)

0.444

1 (0.3)

1 (0.5)

0 (0.0)

0.999

116 (38)

68 (37)

48 (39)

0.783

24 (7.8)

15 (8.2)

9 (7.3)

0.764

Deep sternal infection, n (%)

1 (0.3)

0 (0.0)

1 (0.8)

0.404

Cerebrovascular accident, n (%)

8 (2.6)

5 (2.7)

3 (2.4)

0.999

11 (3.6)

5 (2.7)

6 (4.8)

0.361

5 (1.6)

2 (1.1)

3 (2.4)

0.397

Prolonged ventilation >24 h, n (%)

47 (15)

24 (13)

23 (19)

0.195

GI bleeding/other GI complication, n (%)

14 (4.6)

6 (3.3)

8 (6.5)

0.191

Tracheotomy, n (%)

13 (4.2)

8 (4.3)

5 (4.0)

0.888

Percutaneous/open gastrostomy, n (%)

13 (4.2)

6 (3.3)

7 (5.6)

0.337

Hospital stay after surgery (days)

10.8±8.3

10.1±7.9

11.7±8.7

0.096

Discharged home, n (%)

177 (60.0)

124 (70.5)

53 (44.5)

<0.001

48 (16.2)

21 (11.9)

27 (22.7)

0.013

Myocardial infarction, n (%)
Atrial fibrillation, n (%)
Permanent pacemaker placement, n (%)

Renal dysfunction, n (%)
Newly required hemodialysis, n (%)

Readmission, n (%)

Data are presented as mean ± standard deviation or number (percentage).
IABP, intra-aortic balloon pump; GI, gastrointestinal.

Operative Technique
Operation was performed via either full median sternotomy or
partial right upper hemi-sternotomy, under standard cardiopulmonary bypass and antegrade and retrograde cardioplegic
arrest. Through a transverse aortotomy, the aortic prosthesis
was implanted in a supra-annular position with pledgetted mattress sutures. In patients requiring coronary revascularization
to the left anterior descending artery, the left internal mammary artery was used as an in-situ graft unless patient-specific
factors precluded the use of this conduit.
Statistical Analysis
Statistical analysis was performed with SPSS 11.0 software

(SPSS 11.0, Chicago, IL, USA). Difference in continuous variables was analyzed using independent sample Student’s t-tests.
Categorical variables were compared by chi-square analysis,
or the Fisher exact test when appropriate. Mortality data were
analyzed by the Kaplan-Meier survival analysis, with comparisons between groups performed using the log-rank test.
Independent long-term risk factors for mortality were identified using the Cox proportional hazards regression model;
hazard ratio (HR) as well as its 95% confidence interval (CI)
was obtained. All P values were 2-sided and P<0.05 was considered to be statistically significant.
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Table 5. Operative Mortality
All patients (n=308)

Age 70–79 years (n=184)

Age 80–92 years (n=124)

Observed

Expected

Observed

Expected

Observed

Expected

12/308 (3.9%)

4.8%

7/184 (3.8%)

3.8%

5/124 (4.0%)

6.3%

   Isolated AVR

8/166 (4.8%)

4.0%

5/98 (5.1%)

3.1%

3/68 (4.4%)

5.3%

   AVR + CABG

4/142 (2.8%)

5.8%

2/68 (2.3%)

4.7%

2/56 (3.6%)

7.5%

4/169 (2.4%)

3.1%

1/105 (1.0%)

Operative mortality

STS-PROM
   <7.5%
   >
– 7.5–<15%

5/274 (1.8%)

3.7%

   5/27 (18.5%)

10.1%

   >
– 15%

    2/7 (28.6%)

29.1%

3/11 (27.3%)
0/4 (0%)

4.6%

9.8%

2/16 (12.5%)

10.4%

18.8%

2/3 (66.7%)

42.7%

AVR, aortic valve replacement; CABG, coronary artery bypass grafting; STS-PROM, Society of Thoracic Surgeons
Predicted Risk of Mortality.

Figure 1. Kaplan-Meier curve of survival for age 70–79 vs. age 80–92
years.

Results
Demographics
The preoperative demographics of this patient cohort are shown
in Table 1. The mean age was 78.5±5.0 years; 184 patients
were aged 70–79 and 124 patients were aged 80–92 years.
The younger group of patients were more likely to have hypertension and a higher body mass index, as well as body surface
area greater than patients aged 80–92. Other than the aforementioned data points, there was no significant difference regarding
preoperative comorbidities between these age groups. Preoperative hemodynamics and cardiac profiles are shown in
Table 2. The patients aged 80–92 were more likely to have
had a previous myocardial infarction (31/124 vs. 26/184, P=
0.016) and to have symptoms of congestive heart failure compared with patients aged 70–79 (32/124 vs. 29/184, P=0.032).
Overall New York Heart Association (NYHA) class was 2.6±
0.9 and 74.2% of patients aged 80-92 were either in class III
or IV compared with 47.3% of patients aged 70–79 (P<0.001).
As expected, the STS-PROM was significantly higher in the
patients aged 80–92 (6.3±7.3%, vs. 3.8±3.1% in the patients
aged 70–79, P=0.001). Operative data are shown in Table 3,
and there was no significant difference between the 2 groups.

Postoperative Outcomes
Postoperative comorbidities are listed in Table 4. The most
common postoperative complication was atrial fibrillation
(116/308, 37.8%), followed by a need for ventilation for a
duration of greater than 24 h (47/308, 15.3%), and then a requirement of permanent pacemaker (24/308, 7.8%). Despite
the difference in average age between the 2 groups, there was
no significant difference regarding postoperative complications
between them.
The average length of hospital stay after the surgery was
10.1±7.9 days and 11.7±8.7 days for patients aged 70–79 and
80–92, respectively (P=0.096). The older group was less likely
to be discharged home (53/124, 44.5% vs. 124/184, 70.5%,
P<0.001) and more likely to be readmitted within 30 days after
surgery than patients aged 70–79 (27/124, 22.7% vs. 21/184,
11.9%, P=0.013). The overall operative mortality rate was 3.9%
and there was no significant difference between the 2 age
groups (Table 5).
Long-Term Follow-up
Actuarial survival of the 2 age groups is shown in Figure 1.
Survival at 1, 3, 5, and 10 years in patients aged 70–79 was
91.6%, 85.1%, 77.2%, and 38.0%, respectively, as compared
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Figure 2. Kaplan-Meier curve of survival for non-diabetic patients vs. diabetic patients.

with 84.1%, 75.7%, 63.0%, and 21.7% in patients aged 80–
92 (P=0.002). The Cox regression model revealed that independent predictors for worse long-term survival included:
diabetes (HR 2.12; 95%CI 1.41–3.20; P<0.001, Figure 2); preoperative shock (HR 2.65; 95%CI 1.41–6.67; P=0.039); left
ventricular ejection fraction (LVEF) ≤40% (HR 1.59; 95%CI
1.04–2.41; P=0.032); NYHA class III or IV (HR 1.59; 95%CI
1.02–2.47; P=0.040); and age (per 1-year increment, HR 1.09;
95%CI 1.04–1.13; P<0.001).

Discussion
Mortality
Our study showed reasonable and durable results following
AVR for AS in elderly patients. Although the proportion of
elderly patients with multiple comorbidities is expanding, operative outcomes following AVR were still improving in the past
decade.4 Brown et al published the outcomes of isolated AVR
in North America by analyzing the STS National Database,
comprising 108,687 patients, and compared the mortality rates
in 1997 with those in 2006. In their analysis, patients aged
70–75 had a mortality rate of 3.2% in 1997 and 2.9% in 2006;
for patients aged 80–85, the mortality rate was 6.3% in 1997
and 4.9% in 2006.4 In single-center-based studies published
between 2004 and 2010, the mortality rate of AVR in octogenarians ranged from 3.0% to 10.6% for isolated AVR and from
8.4% to 13.0 % for AVR with concomitant CABG.4–10,15,16
In our study, patients aged 80–92 who underwent isolated
AVR or AVR with CABG showed an acceptable mortality rate
of 4.0%, comparable to the 3.8% mortality rate in patients aged
70–79. Moreover, if the STS-PROM is less than 7.5%, the observed operative mortality rates in both age groups surpassed
expected mortality rates with an observed to expected (O/E)
ratio of 0.49. This trend was also seen in patients who required
the concomitant CABG (O/E ratio of 0.48, Table 5). These
improvements in operative outcome in the past decade could
be related to multiple factors, including patient selection and
perioperative management. Stamou et al suggested that goal-

directed, multidisciplinary protocols and quality improvement
program were associated with improved operative outcome in
cardiac surgery.17 We believe that, with the elderly, especially
those aged 80 years or older, goal-oriented strategies such as
early extubation, judicious sedation management, medication
dosing based on renal or liver function, early involvement of
physical or occupational therapists, and speech/swallow specialists are all indispensable.
Risk Factors for Long-Term Survival
As expected, age was identified as an independent risk factor
for poor long-term survival. Other risk factors such as diabetes
mellitus, existence of preoperative shock, LVEF ≤40%, and
preoperative NYHA class III or IV also significantly affected
long-term results in our patient cohort. In previous studies,
other risk factors such as urgency of the operation and preoperative renal dysfunction or stroke have been reported;6,7,11
however, these did not affect our patients’ outcomes. Although
identifying the high-risk population for AVR has been attempted,16 an ideal model is not currently established to precisely identify the high-risk patients. STS-PROM score and
the European System for Cardiac Operative Risk Evaluation
(EuroSCORE) have been used as part of the inclusion/exclusion criteria for the TAVI trial and to quantify the operative
risk of conventional AVR in that trial.12 However, the possibility of overestimating the operative mortality rates by using
these risk-prediction models and the inescapable discrepancy
between the estimated and observed mortality rate has been
acknowledged.9
Concomitant CABG
Our data showed that concomitant CABG did not alter shortor long-term mortality in the elderly patients. Similar to that
associated with isolated AVR, the operative mortality of AVR
with concomitant CABG has shown constant improvement,
from 6.3% in 2001 to 4.4% in 2010 in the STS database.18
Patients who required coronary revascularization were not
included in the recent TAVI trial.12 Thus, a patient with severe
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AS and coronary artery disease should undergo conventional
AVR with concomitant CABG as the standard procedure of
choice. The importance of appropriate revascularization in
this cohort is further emphasized by the evidence of left ventricular diastolic dysfunction and impaired subendocardial
function as an age-associated alteration of the ventricle in
the elderly population.19 The prevalence of using an internal
mammary artery graft in elderly patients has contributed to the
improvement in operative outcomes.20
Complications
Interestingly, there was no difference in the postoperative
complication rate between the patients aged 70–79 and those
aged 80–92, even though the patients aged 80–92 had worse
preoperative NYHA functional class, advanced chronological
age, and of course, higher STS-PROM scores. However, our
study revealed that patients aged 80–92 were more likely to
be discharged to rehabilitation facilities or other medical
facilities and more likely to be readmitted after surgery than
patients aged 70–79. The relatively high incidence of discharge
to rehabilitation facilities and of postoperative readmission
could suggest a prolonged physical or functional recovery
from surgery in elderly patients and could become an obstacle
to the patients’ regaining normal lives within their limited life
expectancy. Additionally, we found that approximately 4% of
patients required postoperative tracheotomy and/or gastrostomy
tube placement. Although these procedures were unavoidable
during postoperative care, the modality to decrease these complications remains an unsolved issue in current practice. The
less-invasive transcatheter valve implantation procedure may
offer the benefit of decreasing such complications. Accumulating results regarding postoperative comorbidities in
the elderly population undergoing the TAVI procedure will be
followed with continued attention. Although not shown in our
study, the reoperation rate, especially in patients who received
a bioprosthetic valve, is a vital factor in the quality measure
of AVR; however, the beneficial effect of advanced age on
the development of structural valvular deterioration following
AVR has been acknowledged.21
Study Limitations
Because this study was a retrospective review at a single institution, there are several inherent limitations. First, survival
status was drawn only from the Social Security Death Index;
information such as cause of death (cardiac or non-cardiac)
and comorbidities after discharge from the institution were not
investigated in this study. Although we demonstrated a significant difference in the ratio of discharge to home between
age groups, the disposition placement decisions were made
by different physical therapists and physicians, so the reason
for placement might vary. Second, after referral from the cardiologist, the decision to bring the patients to the operating
room is determined by each surgeon; there might be patients
who looked too ill or frail and were not included in the study,
thus causing selection bias. In addition to the factors listed in
STS-PROM or EuroSCORE, each surgeon’s decision was also
based on objective data or even the surgeon’s “impression” to
some extent, such as the patient’s physical and emotional activity, intellectual function, and family support structure. Frailty
is another important element that affects the operative outcome,22 although it was not evaluated in this study. Although
quantifying these factors cannot be easily done, this field is
definitely in need of further investigation. Even considering the
existence of patient selection bias, we believe that our operative results are based on and directed by the updated guide-

lines for surgical indication and postoperative management;
therefore, our results can be seen as a benchmark of operative
results of AVR in current practice.

Conclusion
In conclusion, we confirmed durable results after conventional
AVR with or without concomitant CABG in elderly patients
in a single-center retrospective review. Risk of mortality
was reasonably low and even surpassed predicted mortality in
relatively low-risk patients as well as patients requiring concomitant CABG. Postoperative factors such as readmission,
transferral to rehabilitation facilities, and gastrostomy and/or
tracheotomy placement might significantly affect elderly patients.
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